Yoga demonstrates favorable effects on systemic inflammation, stress, the cardiac autonomic nervous system, and cardiovascular risk factors, though evidence for reducing clinical events remains limited.
Does yoga improve cardiovascular risk factors and outcomes in patients with or at risk for cardiac disease?
Yoga shows promise as a lifestyle intervention for cardiovascular disease management, though large, well-designed randomized trials are needed to confirm clinical benefits.
PURPOSE: Cardiovascular disease continues to be the leading cause of morbidity and mortality around the world. Yoga, a combination of physical postures (asana), breathing exercises (pranayama), and meditation (dhyana), has gained increasing recognition as a form of mind-body exercise. In this narrative review, we intended to review the emerging evidence assessing the physiologic and clinical effects of yoga on the cardiovascular system and the potential role of yoga as a component of comprehensive cardiac rehabilitation. METHODS: We searched PubMed, Google Scholar, Embase, and Cochrane databases for literature related to cardiovascular effects of yoga from inception up until 2017. RESULTS: Yoga has been shown to have favorable effects on systemic inflammation, stress, the cardiac autonomic nervous system, and traditional and emerging cardiovascular risk factors. CONCLUSIONS: Yoga has shown promise as a useful lifestyle intervention that can be incorporated into cardiovascular disease management algorithms. Although many investigators have reported the clinical benefits of yoga in reducing cardiovascular events, morbidity, and mortality, evidence supporting these conclusions is somewhat limited, thereby emphasizing the need for large, well-designed randomized trials that minimize bias and methodological drawbacks.
Guddeti et al. (Thu,) conducted a review in Cardiovascular disease. Yoga was evaluated on Physiologic and clinical effects on the cardiovascular system. Yoga demonstrates favorable effects on systemic inflammation, stress, the cardiac autonomic nervous system, and cardiovascular risk factors, though evidence for reducing clinical events remains limited.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: